Daniel D. Dressler

Jan 16, 2025 | jwatch.org | Daniel D. Dressler

Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing In patients with hip fracture and an elevated troponin level, rapid surgical intervention was associated with lower mortality. In the HIP ATTACK trial ( NEJM JW Gen Med Mar 15 2020 and Lancet 2020; 395:698), nearly 3000 patients who presented with hip fracture after low-energy trauma (e.g., ground-level fall) were randomized to undergo either accelerated surgery (i.e., within 6 hours) or standard-timing surgery (i.e., within 24 hours).

Jan 9, 2025 | jwatch.org | Daniel D. Dressler

Daniel D. Dressler, MD, MSc, MHM, FACP, reviewing A meta-analysis reaffirms generally better outcomes with therapeutic than with prophylactic anticoagulation - with some exceptions. Patients hospitalized with COVID-19 infection have excess risk for thromboembolic complications.

Jan 9, 2025 | jwatch.org | Daniel D. Dressler

Dec 30, 2024 | jwatch.org | Daniel D. Dressler

Daniel D. Dressler, MD, MSc, MHM, FACP In 2024, NEJM Journal Watch covered many studies that are not included in our detailed Year in Review feature but still were important contributions to the inpatient literature. Here are brief synopses of some of those studies.

Dec 30, 2024 | jwatch.org | Daniel D. Dressler

Daniel D. Dressler, MD, MSc, MHM, FACP New trials address timing of antiplatelet therapy for ischemic stroke and anticoagulation for embolic stroke. Studies published in the past year informed us about the optimal duration of dual antiplatelet therapy (DAPT), which is indicated for many patients who suffer thrombotic strokes, and about when anticoagulation should be initiated after thrombotic or embolic strokes.